Medigene AG
MDGEFOTCHealthcare● Active
$2.59
+$0.00(+0.00%)
Market Cap$38170366
P/E Ratio—
52W High$2.59
52W Low$0.1
Medigene AG (MDGEF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · MDGEF · as of 2026-06-15
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2023-12 | 2022-12 | 2021-12 | 2020-12 | 2019-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $6.03M | $31.25M | $10.46M | $8.00M | $10.51M |
| Cost of Revenue | $1.64M | $23.84M | $4.79M | $7.76M | $2.70M |
| Gross Profit | $4.39M | $7.41M | $5.67M | $0.24M | $7.81M |
| Gross Margin %(computed) | 72.77% | 23.72% | 54.24% | 2.97% | 74.31% |
| Operating Expenses | |||||
| R&D Expenses | $11.54M | $7.18M | $9.95M | $18.55M | $20.81M |
| G&A Expenses | $9.32M | $7.69M | $2.82M | $3.69M | $6.63M |
| Total Operating Expenses | $20.54M | $16.53M | $16.19M | $27.44M | $28.09M |
| Operating Income | ($16.15M) | ($9.12M) | ($10.51M) | ($27.20M) | ($20.28M) |
| Operating Margin %(computed) | -267.63% | -29.19% | -100.46% | -339.89% | -192.96% |
| Interest Income | $0.14M | $0.03M | $0.02M | $0.06M | $0.16M |
| Interest Expense | $0.54M | $0.63M | $0.34M | $0.40M | $0.45M |
| Income Before Tax | ($16.59M) | ($9.37M) | ($10.28M) | ($28.40M) | ($19.92M) |
| Income Tax Expense | ($0.41M) | ($1.04M) | ($0.30M) | $0.47M | $0.04M |
| Net Income | ($16.18M) | ($8.33M) | ($9.98M) | ($28.88M) | ($19.96M) |
| Net Margin %(computed) | -268.10% | -26.66% | -95.41% | -360.85% | -189.92% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.32 | $-0.64 | $-0.77 | $-2.23 | $-1.54 |
| Wtd Avg Shares | 12.28M | 12.93M | 12.93M | 12.93M | 12.93M |
| EBITDA | ($15.45M) | $13.11M | ($6.51M) | ($21.53M) | ($17.10M) |
| EBITDA Margin %(computed) | -255.97% | 41.96% | -62.23% | -269.08% | -162.65% |
Data source: Financial Modeling Prep · Last updated: 2026-06-15 · EUR · M
Explore more Medigene AG data
About Medigene AG (MDGEF) Income Statement
Medigene AG (MDGEF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2023, MDGEF reported revenue of $0.01B, gross profit of $0.00B (gross margin 72.77%), and net income of ($0.02B) — a net profit margin of -268.10%.
Frequently asked questions
MDGEF · 4 questionsMedigene AG (MDGEF) reported revenue of $0.01B for 2023, down 80.7% year-over-year.
MDGEF revenueMDGEF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-15